Skip to main content
OPKO Health Inc. logo

OPKO Health Inc. — Investor Relations & Filings

Ticker · OPK ISIN · US68375N1037 LEI · 529900A4S2D4OGOJLL02 TA Human health and social work activities
Open in API
Filings indexed 3,780 across all filing types
Latest filing 2025-03-15 Remuneration Information
Country US United States of America
Listing TA OPK

About OPKO Health Inc.

https://www.opko.com

OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.

Recent filings

Filing Released Lang Actions
Proxy Statement for the 2025 Annual Meeting of Stockholders to be held on April 23, 2025
Remuneration Information Classification · 99% confidence The document explicitly contains the header "DEF 14A Proxy" and the text states "Attached hereto is a report on*DEF 14A Proxy*". According to the definitions, DEF 14A corresponds to Remuneration Information, which is often included in Proxy Statements (DEF 14A). Since the document is short (1746 chars) and announces the attachment of the report rather than containing the full content, it could potentially be an RPA. However, the primary identifier is the specific form type 'DEF 14A Proxy', which maps directly to the 'DEF 14A' code in the provided schema, which is defined as 'Remuneration Information'. Given the direct mention of the form type, classifying it as the specific report type (DEF 14A) is more accurate than the general announcement type (RPA), unless the content was purely an announcement of the filing date. Since the document title/subject is clearly DEF 14A, I will use that code.
2025-03-15 English
Notice of the 2025 Annual Meeting of Stockholders to be held on April 23, 2025
AGM Information Classification · 99% confidence The document explicitly contains a 'NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS' and is titled 'PROXY STATEMENT FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS'. It details the proposals to be voted on at the Annual Meeting (election of directors, Say on Pay, ratification of auditors) and provides instructions on voting via proxy or virtually. This content is characteristic of a Proxy Statement, which solicits shareholder votes for the Annual General Meeting. The corresponding code is AGM-R, although DEF 14A is often used for the definitive proxy statement, AGM-R covers the meeting materials themselves. Given the focus on the meeting notice and proxy solicitation, AGM-R is the most appropriate fit among the provided options, as it covers AGM materials.
2025-03-15 English
Notice of the 2025 Annual Meeting of Stockholders to be held on April 23, 2025
Remuneration Information Classification · 98% confidence The document explicitly contains the header "DEF 14A" and mentions "Notice of the 2025 Annual Meeting of Stockholders". The text states, "Attached hereto is a report on*DEF 14A Notice of the 2025 Annual Meeting of Stockholders to be held on April 23, 2025.*". A DEF 14A is the official filing for Proxy Statements/Information Statements related to soliciting shareholder votes for an annual meeting. Although it mentions an attachment, the core content identifies the filing type as a Proxy Statement/Information Statement, which maps directly to the 'DEF 14A' code in the provided definitions, which is specifically defined as 'Remuneration Information' but the presence of 'DEF 14A' and 'Notice of Annual Meeting' strongly points to the Proxy Statement category, which is listed as DEF 14A in the provided schema definitions. Given the explicit mention of 'DEF 14A' and the context of an Annual Meeting Notice, DEF 14A is the most accurate classification, overriding the general RPA/RNS fallback based on the specific form name.
2025-03-15 English
2024 Annual Report on Form 10-K
Annual Report Classification · 100% confidence The document is explicitly titled 'FORM 10-K' and identifies itself as an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934'. It includes standard SEC filing headers, a table of contents for a 10-K, and references to fiscal year-end reporting. It is clearly the official annual report of OPKO Health, Inc. FY 2024
2025-03-15 English
2024 Annual Report on Form 10-K
Report Publication Announcement Classification · 100% confidence The document is a short notification (1795 characters) from the Israel Securities Authority (MAGNA system) that explicitly states 'Attached hereto is a report on Annual Report on Form 10-K'. Per the 'MENU VS MEAL' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA). FY 2024
2025-03-15 English
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses
M&A Activity Classification · 98% confidence The document is a press release announcing that Labcorp has entered into an agreement to acquire select assets of BioReference Health from OPKO Health. It details the transaction terms, strategic rationale, and expected impact. This type of announcement, concerning a major corporate transaction like an acquisition, falls under the category of M&A Activity (TAR). It is not a full financial report (10-K or IR), an earnings release (ER), or a general regulatory filing (RNS), but specifically details a merger/takeover proposal. Keywords supporting this classification include: 'Announces Acquisition', 'entered into an agreement', 'transaction', 'purchase price', and 'proposed acquisition'.
2025-03-11 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.